Ventas, Inc. VTR
As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property value. Our partnerships extend to leading care providers, developers, research and medical institutions, innovators, and healthcare organizations, all of whom benefit from the significant demographic trend of an aging population. For over two decades, Ventas has pursued a steadfast and effective strategy: maintaining a high-quality, diverse portfolio of assets and varied capital streams to skillfully navigate market fluctuations. A dedicated and experienced team collaborates with industry-leading partners to generate consistent, increasing cash flows and superior returns on a strong balance sheet, ultimately enriching Ventas's shareholders. As of September 30, 2020, Ventas either owned outright or managed through unconsolidated joint ventures approximately 1,200 properties.
Business overview written from the company's own Form 10-K (Item 1), filed 2026-02-06 — refreshed whenever it files a new one. The figures above are current; see its SEC filings. ✓ From the 10-K
Plain-English: the Snapshot is the quick read — what it pays you (yield, dividend), how its cash flow looks (FFO/AFFO, Price/OCF) and how much debt it carries. Switch to Expert in the header to hide these explanations.
Snapshot
Reported FFO / Normalized FFO / leverage are from the Q1 2026 earnings release (filed 2026-04-27) — 8-K, EX-99.1 ✓ Verified to filing.
Yield uses the latest declared dividend, annualized (latest regular payout × frequency; special/liquidating distributions excluded) — an announced-but-not-yet-declared change isn't reflected until it has an ex-date. FFO, AFFO and Net debt / Adj. EBITDA are the company's reported figures from its latest earnings 8-K. Price/OCF and payout use GAAP operating cash flow. NAV premium and credit ratings have no free source yet. See Methodology.
$10,000 invested
Illustrative income only, at today's price and latest declared dividend — it excludes price changes, dividend cuts and taxes. Not a forecast.
Model VTR yourself — any amount, shares, per-payment & a multi-year DRIP projection →
Balance sheet (latest FY: 2025)
Debt-maturity ladder, fixed/floating split, secured/unsecured and coverage ratios come from the supplemental — not yet ingested.
Financial history
| FY | Revenue | Net income | D&A | EBITDA | Op. cash flow |
|---|---|---|---|---|---|
| 2025 | $5.83B | $251.38M | $1.38B | $2.24B | $1.68B |
| 2024 | $4.92B | $81.15M | $1.28B | $1.94B | $1.34B |
| 2023 | $4.50B | $-40.97M | $1.41B | $1.95B | $1.19B |
| 2022 | $4.13B | $-47.45M | $1.21B | $1.62B | $1.15B |
| 2021 | $3.83B | $49.01M | $1.22B | $1.72B | $1.04B |
| 2020 | $3.80B | $439.15M | $1.13B | $1.94B | $1.45B |
Dividends
Recent regular dividends per share (special distributions excluded), oldest → newest.
| Ex-date | Record | Payment | Declared | Amount | Freq. |
|---|---|---|---|---|---|
| 2026-06-30 | 2026-06-30 | 2026-07-16 | 2026-05-13 | $0.52 | Quarterly |
| 2026-03-31 | 2026-03-31 | 2026-04-16 | 2026-02-05 | $0.52 | Quarterly |
| 2025-12-31 | 2025-12-31 | 2026-01-15 | 2025-12-10 | $0.48 | Quarterly |
| 2025-09-30 | 2025-09-30 | 2025-10-16 | 2025-09-18 | $0.48 | Quarterly |
| 2025-06-30 | 2025-06-30 | 2025-07-17 | 2025-05-13 | $0.48 | Quarterly |
| 2025-03-31 | 2025-03-31 | 2025-04-17 | 2025-02-12 | $0.48 | Quarterly |
| 2024-12-31 | 2024-12-31 | 2025-01-16 | 2024-12-10 | $0.45 | Quarterly |
| 2024-10-01 | 2024-10-01 | 2024-10-17 | 2024-09-17 | $0.45 | Quarterly |
| 2024-07-01 | 2024-07-01 | 2024-07-18 | 2024-05-14 | $0.45 | Quarterly |
| 2024-03-28 | 2024-04-01 | 2024-04-18 | 2024-03-12 | $0.45 | Quarterly |
| 2023-12-29 | 2024-01-02 | 2024-01-18 | 2023-12-05 | $0.45 | Quarterly |
| 2023-09-29 | 2023-10-02 | 2023-10-12 | 2023-09-13 | $0.45 | Quarterly |
| 2023-06-30 | 2023-07-03 | 2023-07-13 | 2023-05-16 | $0.45 | Quarterly |
| 2023-03-31 | 2023-04-03 | 2023-04-13 | 2023-03-14 | $0.45 | Quarterly |
| 2022-12-30 | 2023-01-03 | 2023-01-19 | 2022-12-07 | $0.45 | Quarterly |
| 2022-09-30 | 2022-10-03 | 2022-10-14 | 2022-09-16 | $0.45 | Quarterly |
| 2022-06-30 | 2022-07-01 | 2022-07-14 | 2022-05-25 | $0.45 | Quarterly |
| 2022-03-31 | 2022-04-01 | 2022-04-14 | 2022-03-16 | $0.45 | Quarterly |
| 2021-12-31 | 2022-01-03 | 2022-01-19 | 2021-12-07 | $0.45 | Quarterly |
| 2021-09-30 | 2021-10-01 | 2021-10-14 | 2021-09-14 | $0.45 | Quarterly |
| 2021-06-30 | 2021-07-01 | 2021-07-14 | 2021-05-25 | $0.45 | Quarterly |
| 2021-03-31 | 2021-04-01 | 2021-04-14 | 2021-03-17 | $0.45 | Quarterly |
| 2020-12-31 | 2021-01-04 | 2021-01-20 | 2020-12-11 | $0.45 | Quarterly |
| 2020-09-30 | 2020-10-01 | 2020-10-13 | 2020-09-18 | $0.45 | Quarterly |
Coverage (payout of operating cash flow): 57.26%. Tax-character split (ordinary / 199A / capital gain / return of capital) — not disclosed (requires the annual allocation release).
Recent news — VTR
Ventas: Ahead Of Q2 Results, Lots To Like About This Senior-Care REIT
Here Are Tuesday’s Best Wall Street Analyst Research Calls: Adobe, American Airlines, Broadcom, First Solar, Meta Platforms, Shopify, Space-X, Ventas, Waste Managment, and More
Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call
Is Holding Ventas Stock Still a Smart Move for Your Portfolio Now?
Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research
Why Ventas (VTR) is a Great Dividend Stock Right Now
Headlines via Financial Modeling Prep; links open the original publisher in a new tab. Not an endorsement or investment advice.
Other Health Care REITs
Same-store NOI, occupancy, leasing/WALT, top tenants, external-manager fees, development pipeline and (for non-traded vehicles) share-class fees, redemption/gating and NAV methodology are planned modules sourced from supplementals and prospectuses.